S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item

Entrada Therapeutics (TRDA) News Today

$12.95
-0.31 (-2.34%)
(As of 04/12/2024 ET)
SourceHeadline
MarketBeat logoInsider Buying: Entrada Therapeutics, Inc. (NASDAQ:TRDA) Director Acquires 2,600 Shares of Stock
americanbankingnews.com - April 12 at 5:50 AM
insidermonkey.com logoInsiders are Piling into These 5 Healthcare Stocks in 2024
insidermonkey.com - April 12 at 12:03 AM
msn.com logoInsiders Buying America's Car-Mart And 2 Other Stocks
msn.com - April 11 at 7:02 PM
insidertrades.com logoEntrada Therapeutics, Inc. (NASDAQ:TRDA) Director Peter S. Kim Purchases 2,600 Shares
insidertrades.com - April 11 at 6:48 AM
marketbeat.com logoPeter S. Kim Buys 2,600 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock
marketbeat.com - April 10 at 6:42 PM
insidertrades.com logoPeter S. Kim Acquires 1,512 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock
insidertrades.com - April 2 at 4:26 AM
marketbeat.com logoEntrada Therapeutics, Inc. (NASDAQ:TRDA) Director Buys $20,790.00 in Stock
marketbeat.com - April 1 at 6:47 PM
finance.yahoo.com logoDirector Peter Kim Acquires 9,048 Shares of Entrada Therapeutics Inc (TRDA)
finance.yahoo.com - March 27 at 10:44 AM
insidertrades.com logoPeter S. Kim Acquires 3,180 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock
insidertrades.com - March 27 at 5:26 AM
marketbeat.com logoEntrada Therapeutics, Inc. (NASDAQ:TRDA) Director Buys $42,484.80 in Stock
marketbeat.com - March 26 at 6:42 PM
insidertrades.com logoInsider Buying: Entrada Therapeutics, Inc. (NASDAQ:TRDA) Director Purchases 900 Shares of Stock
insidertrades.com - March 22 at 11:12 AM
marketbeat.com logoEntrada Therapeutics, Inc. (NASDAQ:TRDA) Director Peter S. Kim Purchases 900 Shares
marketbeat.com - March 21 at 7:58 PM
marketbeat.com logoEntrada Therapeutics, Inc. (NASDAQ:TRDA) to Post Q1 2024 Earnings of ($0.40) Per Share, HC Wainwright Forecasts
marketbeat.com - March 20 at 5:45 AM
finance.yahoo.com logoEntrada Therapeutics, Inc. (NASDAQ:TRDA) Analysts Just Slashed This Year's Estimates
finance.yahoo.com - March 19 at 9:52 AM
marketbeat.com logoHC Wainwright Reaffirms "Buy" Rating for Entrada Therapeutics (NASDAQ:TRDA)
marketbeat.com - March 18 at 5:32 PM
markets.businessinsider.com logoEntrada Therapeutics: Buy Rating on Strong Financials and Promising Clinical Pipeline
markets.businessinsider.com - March 18 at 1:40 PM
marketbeat.com logoEquities Analysts Offer Predictions for Entrada Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:TRDA)
marketbeat.com - March 18 at 1:27 AM
markets.businessinsider.com logoTD Cowen Reaffirms Their Buy Rating on Entrada Therapeutics Inc (TRDA)
markets.businessinsider.com - March 13 at 8:49 PM
finanznachrichten.de logoEntrada Therapeutics, Inc.: Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
finanznachrichten.de - March 13 at 10:48 AM
benzinga.com logoRecap: Entrada Therapeutics Q4 Earnings
benzinga.com - March 13 at 10:48 AM
globenewswire.com logoEntrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
globenewswire.com - March 13 at 7:00 AM
benzinga.com logoEntrada Therapeutics Stock (NASDAQ:TRDA) Insider Trades
benzinga.com - February 23 at 2:23 AM
finance.yahoo.com logo‘Time to Pull the Trigger,’ Says Oppenheimer About These 3 Stocks
finance.yahoo.com - January 29 at 8:27 AM
marketbeat.com logoEntrada Therapeutics, Inc. (NASDAQ:TRDA) CEO Sells $15,990.00 in Stock
marketbeat.com - January 18 at 7:24 PM
finance.yahoo.com logoAmicus (FOLD) Issues Preliminary Revenue Results for FY23
finance.yahoo.com - January 8 at 11:58 AM
msn.com logoOppenheimer Initiates Coverage of Entrada Therapeutics (TRDA) with Outperform Recommendation
msn.com - January 6 at 8:22 AM
marketbeat.com logoEntrada Therapeutics (NASDAQ:TRDA) Now Covered by Oppenheimer
marketbeat.com - January 5 at 8:11 AM
finance.yahoo.com logoBEAM Stock Rallies More Than 25% in 3 Months: What Next?
finance.yahoo.com - January 3 at 1:30 PM
finance.yahoo.com logoEntrada Therapeutics Promotes Nathan J. Dowden to President
finance.yahoo.com - January 3 at 8:30 AM
finance.yahoo.com logoEntrada Therapeutics Inc CFO Kory Wentworth Sells 12,500 Shares
finance.yahoo.com - December 28 at 9:29 AM
marketbeat.com logoKory James Wentworth Sells 10,206 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock
marketbeat.com - December 26 at 6:41 PM
marketbeat.com logoEntrada Therapeutics, Inc. (NASDAQ:TRDA) CEO Dipal Doshi Sells 1,000 Shares
marketbeat.com - December 22 at 6:52 PM
finance.yahoo.com logoAnavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA
finance.yahoo.com - December 20 at 1:05 PM
finance.yahoo.com logoRoche's (RHHBY) sBLA for Xolair Gets FDA Priority Review Tag
finance.yahoo.com - December 20 at 1:05 PM
benzinga.com logoEntrada Therapeutics Stock (NASDAQ:TRDA) Dividends: History, Yield and Dates
benzinga.com - December 11 at 1:30 PM
finance.yahoo.com logoPfizer's (PFE) Multiple Myeloma Drug Elrexfio Gets Nod in EU
finance.yahoo.com - December 11 at 1:30 PM
benzinga.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Entrada Therapeutics, Inc. - TRDA
benzinga.com - November 29 at 6:46 PM
finance.yahoo.com logoImmunovant (IMVT) Up on Positive Initial IMVT-1402 MAD Study Data
finance.yahoo.com - November 29 at 1:45 PM
markets.businessinsider.com logoHC Wainwright & Co. Maintains Buy Rating for Entrada Therapeutics: Here's What You Need To Know
markets.businessinsider.com - November 27 at 1:40 PM
finance.yahoo.com logoEntrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug
finance.yahoo.com - November 23 at 5:02 PM
finance.yahoo.com logoBiotech Stock Roundup: BMY, TSVT Down on Setback, TRDA, MOR Offer Updates
finance.yahoo.com - November 23 at 12:01 PM
markets.businessinsider.com logoPositive Prospects for Entrada Therapeutics Despite FDA Hold: An Analyst’s Buy Rating Justification
markets.businessinsider.com - November 23 at 7:00 AM
bizjournals.com logoEntrada shares slide as FDA maintains freeze on Duchenne drug
bizjournals.com - November 22 at 5:01 PM
markets.businessinsider.com logoWhy Is Neuromuscular Disease Focused Entrada Therapeutics Shares Trading Lower Today?
markets.businessinsider.com - November 22 at 5:01 PM
marketwatch.com logoEntrada Therapeutics Shares Tumble 27% After FDA Keeps Clinical Hold
marketwatch.com - November 22 at 12:00 PM
markets.businessinsider.com logoEntrada Therapeutics Says FDA Declines To Lift Clinical Hold On ENTR-601-44 IND Application
markets.businessinsider.com - November 22 at 12:00 PM
finance.yahoo.com logoEntrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular Dystrophy
finance.yahoo.com - November 22 at 12:00 PM
markets.businessinsider.com logoEntrada Therapeutics’ Promising Phase 1 Trial and Broad Tissue Distribution Profile Underpin Buy Rating
markets.businessinsider.com - November 9 at 10:49 AM
finance.yahoo.com logoNew Forecasts: Here's What Analysts Think The Future Holds For Entrada Therapeutics, Inc. (NASDAQ:TRDA)
finance.yahoo.com - November 9 at 10:49 AM
morningstar.com logoEntrada Therapeutics Inc TRDA
morningstar.com - November 8 at 6:18 PM
Get Entrada Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRDA and its competitors with MarketBeat's FREE daily newsletter.

Did You Get Your Free Bitcoin Yet? (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

TRDA Media Mentions By Week

TRDA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TRDA
News Sentiment

1.03

0.64

Average
Medical
News Sentiment

TRDA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TRDA Articles
This Week

7

1

TRDA Articles
Average Week

Get Entrada Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRDA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TRDA) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners